上海百心安生物技术股份有限公司（“百心安-B”，股票代码：02185）于2026年8月6日公布截至2026年7月31日的证券变动月报表，报告期内公司股本结构未发生任何变动。
根据报告显示，百心安-B于本月末普通股H股已发行股份总数保持在235,703,422股，无库存股份，非上市外资股维持在7,713,678股，法定注册股本合计仍为人民币243,417,100元。报告期内，公司不存在新增发行、股份购回或注销，以及库存股变化等情形，股份期权、权证、可换股票据等其他潜在股权安排亦无更新。
公告显示，公司确认其已符合香港联合交易所有限公司相关上市规则要求，维持足够的公众持股量。该公告由执行董事兼联席公司秘书王云磬签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.